National Drug Code (NDC) Database
Accord Healthcare Inc.
-
NDC:
16729-150
-
Nonproprietary Name:
Quetiapine
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
400 mg/1
-
Substance:
QUETIAPINE FUMARATE
-
Start Marketing Date:
2015-12-16
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
ACS Dobfar S.p.A
-
NDC:
52946-0924
-
Nonproprietary Name:
Ceftazidime
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
CEFTAZIDIME
-
Start Marketing Date:
2019-05-22
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
ACS Dobfar S.p.A.
-
NDC:
52946-0500
-
Nonproprietary Name:
Daptomycin
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
DAPTOMYCIN
-
Start Marketing Date:
2009-12-09
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Actavis Pharma, Inc.
-
NDC:
62037-605
-
Nonproprietary Name:
Loratadine and Pseudoephedrine Sulfate
-
Dosage Form:
TABLET, EXTENDED RELEASE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
10; 240 mg/1; mg/1
-
Substance:
LORATADINE; PSEUDOEPHEDRINE SULFATE
-
Start Marketing Date:
2003-02-21
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
10903-101
-
Nonproprietary Name:
Piperazine Citrate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
PIPERAZINE CITRATE
-
Start Marketing Date:
2025-11-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Adare Pharmaceuticals Inc
-
NDC:
59917-228
-
Nonproprietary Name:
Amphetamine Sulfate
-
Dosage Form:
TABLET, ORALLY DISINTEGRATING
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
20 mg/20mg
-
Substance:
DEXTROAMPHETAMINE SULFATE
-
Start Marketing Date:
2019-05-16
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
CII
-
Certified Through:
2026-12-31
Adare Pharmaceuticals Srl
-
NDC:
57298-808
-
Nonproprietary Name:
Pancrelipase Zenpep (pancrelipase) delayed-release bulk capsules
-
Dosage Form:
CAPSULE, DELAYED RELEASE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
252600; 60000; 189600 [USP'U]/1; [USP'U]/1; [USP'U]/1
-
Substance:
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
-
Start Marketing Date:
2024-01-02
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Adare Pharmaceuticals, Inc.
-
NDC:
59917-256
-
Nonproprietary Name:
valbenazine
-
Dosage Form:
CAPSULE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
80 mg/1
-
Substance:
VALBENAZINE TOSYLATE
-
Start Marketing Date:
2024-04-30
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
69115-002
-
Nonproprietary Name:
Metronidazole Benzoate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
METRONIDAZOLE BENZOATE
-
Start Marketing Date:
2018-07-16
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
-
NDC:
52946-0930
-
Nonproprietary Name:
Imipenem
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
IMIPENEM
-
Start Marketing Date:
2022-10-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.